Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation [Brief Reports]

Conclusions— Dabigatran treatment within 24 hours of minor stroke is feasible. A larger randomized trial is required to confirm the safety and efficacy of this treatment approach. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT 01769703.
Source: Stroke - Category: Neurology Authors: Tags: Anticoagulants Brief Reports Source Type: research